When was Dopavision founded?

Dopavision was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Dopavision located?

Dopavision is headquartered in Berlin, Germany. It is registered at Krausenstraße 9-10 10117 Berlin.

Which legal entities is Dopavision associated with?

Dopavision is associated with Dopavision Gmbh and 1 other.

How many employees does Dopavision have?

As of Aug 31, 2026, the latest employee count at Dopavision is 8.

Is Dopavision a funded company?

Dopavision is a funded company, having raised a total of $17.4M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2018.

When was the latest funding round of Dopavision?

Dopavision's latest funding was a $***** Series A round on Jul 14, 2021, with participation from 4 investors.

Where does Dopavision rank among its competitors?

Dopavision ranks 5th amongst 76 active competitors, of which 10 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was IRIDEX, which secured $10M in Mar, 2025.

Who are the top competitors of Dopavision?

Dopavision's top competitors include Perfuse Therapeutics, IRIDEX and MicroSurgical Technology. Among them, IRIDEX secured the most recent funding round in March, 2025.

Dopavision - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of digital therapeutics for myopia. The technology delivers light stimulation to specific photosensitive cells on the retina that modulate dopamine that helps in the regulation of eye growth. It also provides Myopiax a mobile application for children, providing fun and treatment.

Website: dopavision.com
Email ID: *****@dopavision.com
Registered Address: Krausenstraße 9-10 10117 Berlin

Key Metrics

Founded Year

2017

Location

Berlin, Germany

Stage

Series A

Total Funding

$17.4M in 3 rounds

Latest Funding Round

Series A, Jul 14, 2021, $*****

Investors

Seventure Partners & 10 more

Ranked

5^th among 76 active competitors

Employee Count

8 as on Aug 31, 2026

Similar Companies

Perfuse Therapeutics & 86 more

View Dopavision's full profile

Dopavision is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Dopavision GmbH CIN: F1103_HRB191088B , Germany, Active	Nov 07, 2017	-	-
Dopavision Gmbh CIN: HRB191088 , Germany, Active	Nov 06, 2017	-	-

Dopavision has raised a total funding of $17.4M over 3 rounds. Its first funding round was on 2018. Its latest funding round was a Series A round on Jul 14, 2021 for $*****. 4 investors participated in its latest round. Dopavision has 8 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Dopavision:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 14, 2021	2050874	Series A	3153056	7187812	5324796	3957294
Jun 19, 2019	3244616	Seed	2705451	3620173	8676258	Ralf Meister & 1 more
2018	9117	Grant (prize money)	7761	8393	6859	Bmbf

Access funding benchmarks and valuations. Sign up today!

View details of Dopavision's funding rounds and investors

The founders of Dopavision is Stefan Zundel.

Here are the details of Dopavision's key team members:

Stefan Zundel: Former Co-Founder of Dopavision.

View details of Dopavision's Founder profiles and Board Members

Dopavision's employee count trend

Dopavision has 8 employees as of Aug 26. Here is Dopavision's employee count trend over the years:

Uncover Dopavision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dopavision include Perfuse Therapeutics, IRIDEX and MicroSurgical Technology. Here is the list of Top 10 competitors of Dopavision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Perfuse Therapeutics 2018, San Francisco (United States), Acquired	Developer of therapies to treat eye disorders	-	Access Industries, Lilly Asia Ventures & 3 others	49/100
2nd	IRIDEX 1989, Mountain View (United States), Public	Manufacturer of ophthalmic laser systems and surgical instruments for eyes	-	Incubic, Technology Partners & 1 others	48/100
3rd	MicroSurgical Technology 1976, Redmond (United States), Acquired	Develops a portfolio of Surgical tools for Ophthalmic surgeries	-	-	47/100
4th	Appasamy Associates 1978, Chennai (India), Acquired	Developer of ophthalmic instruments and pharmaceutical products	-	BIRAC	46/100
5th	Dopavision 2017, Berlin (Germany), Series A	Developer of a digital therapeutic for myopia	$17.4M	Flying Health, Boehringer Ingelheim Venture Fund ... & 9 others	45/100
6th	Oertli Instrumente 1955, Berneck (Switzerland), Unfunded	Developer of ophthalmology medical device	-	-	44/100
7th	Keeler 1917, Windsor (United Kingdom), Unfunded	A portfolio of ophthalmic devices	-	-	44/100
8th	Lalji International 2018, Ahmedabad (India), Unfunded	Manufacturer of disposable medical drapes and surgical gowns. The company produces a variety of products for various medical applications, including ophthalmology, gynecology, and general surgery. These products are designed for single-use and contribute to maintaining a sterile environment during procedures. The manufacturing process emphasizes quality control to ensure the safety and efficacy of the products. The company's offerings also include hospital beds and related furniture.	-	-	42/100
9th	Lamellar 2007, Glasgow (United Kingdom), Series C	Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies	$18.4M	Hambro Perks, Invesco & 4 others	42/100
10th	Ziemer Ophthalmology 2005, Basel (Switzerland), Series B	Portfolio of devices for refractive and corneal surgery	$17.4M	BV Partners, HBM Partners & 1 others	40/100